VSee Health, Inc. (NASDAQ:VSEE) introduced its VSee AI Robot at the HIMSS 2026 conference in Las Vegas, marking the first fully autonomous telehealth AI robot that can navigate to patients' bedsides without onsite staff assistance.
The robot enables remote clinicians to conduct virtual rounding, deliver rapid telestroke response, and provide specialist coverage across emergency departments and intensive care units, expanding the reach of VSee’s telehealth platform.
The launch aligns with VSee’s strategy to expand into autonomous in‑hospital solutions and leverage its FedRAMP High authorization, which was granted on October 28, 2025, opening opportunities with federal agencies that require high‑security cloud services.
While the company has faced financial headwinds—its current ratio stood at 0.11 and recent earnings reports show consistent net losses—VSee’s leadership views the robot as a key driver to address staffing shortages and generate new revenue streams in high‑acuity care markets.
Dr. Milton Chen, CEO, said, "We built the VSee AI Robot to solve the hardest problem in healthcare staffing: doing more with less, without sacrificing the human connection at the bedside. This isn't a cart with a screen. This is an autonomous clinical teammate that multiplies what every provider on your team can do." Dr. Imo Aisiku, Co‑CEO, added that the FedRAMP milestone opens doors to government contracts, reinforcing the company’s focus on scaling its telehealth solutions.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.